RIPK2-IN-7

Overview

RIPK2-IN-7 (Compound 10w) is an orally active, selective RIPK2 inhibitor ( IC 50 : 0.6 nM). RIPK2-IN-7 inhibits RIPK2 kinase activity, blocks the nucleotide-binding oligomerization domain (NOD) signaling pathway, and reduces the production of inflammatory factors (such as TNFα). RIPK2-IN-7 can be used in the study of inflammatory bowel disease (IBD).

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > RIP kinase | Products > Signaling Pathways > NOD-like Receptor (NLR) | Products > Signaling Pathways > TNF Receptor

Product Information

• Catalog No.: HY-171592
• CAS No.: 2789711-40-4
• Molecular Formula: C19H22FN5
• Molecular Weight: 339.41
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source